Metraipolis › archive › dc_c346ff181e60

Implications of the 2025 AHA/ACC high blood pressure guidelines on the initiation and intensification of blood pressure-lowering medications among US adults — Europe PMC PMID:41767443

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41767443
DOI
10.1016/j.ajpc.2025.101400
License (as archived)
solo-consultazione
Archived
2026-11-06T17:32:26.259Z
SHA-256 of the archived text
e04ff734c9f7838dca3bf744dfd2075d3888613f70f66da262104a7b4bbdf2de
Stable URL of this page
https://metraipolis.com/documento/dc_c346ff181e60

How to cite

Implications of the 2025 AHA/ACC high blood pressure guidelines on the initiation and intensification of blood pressure-lowering medications among US adults — Europe PMC PMID:41767443 — Europe PMC (en), https://europepmc.org/article/MED/41767443 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c346ff181e60 (Metraipolis archive dc_c346ff181e60, sha256 e04ff734c9f7838dca3bf744dfd2075d3888613f70f66da262104a7b4bbdf2de)
BibTeX
@misc{dcc346ff181e60,
  title = {Implications of the 2025 AHA/ACC high blood pressure guidelines on the initiation and intensification of blood pressure-lowering medications among US adults — Europe PMC PMID:41767443},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41767443},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c346ff181e60; sha256 e04ff734c9f7838dca3bf744dfd2075d3888613f70f66da262104a7b4bbdf2de},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41767443. Agents can read the archived copy with the MCP tool read_document.